Mount Sinai Health System and the pharmaceutical company Sorrento Therapeutics have partnered together for an exciting project. Mount Sinia is supplying blood samples from 15,000 coronavirus patients for Sorrento to identify antibodies and develop a cloning mechanism to mass-produce them. The hope is to produce a three antibody cocktail that is easily scalable and offers protection against a changing virus.